Trial Report Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset, 2024, Wynberg et al

Discussion in 'Long Covid research' started by John Mac, Jul 16, 2024 at 12:39 PM.

  1. John Mac

    John Mac Senior Member (Voting Rights)

    Messages:
    973
    Full title:
    Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset: A prospective cohort study of individuals with mild to critical COVID-19

    Abstract

    Background: After initial COVID-19, immune dysregulation may persist and drive post-acute sequelae of COVID-19 (PASC). We described longitudinal trajectories of cytokines in adults up to 6 months following SARS-CoV-2 infection and explored early predictors of PASC.

    Methods: RECoVERED is a prospective cohort of individuals with laboratory-confirmed SARS-CoV-2 infection between May 2020 and June 2021 in Amsterdam, the Netherlands. Serum was collected at weeks 4, 12 and 24 of follow-up. Monthly symptom questionnaires were completed from month 2 after COVID-19 onset onwards; lung diffusion capacity (DLCO) was tested at 6 months. Cytokine concentrations were analysed by human magnetic Luminex screening assay. We used a linear mixed-effects model to study log-concentrations of cytokines over time, assessing their association with socio-demographic and clinical characteristics that were included in the model as fixed effects.

    Results: 186/349 (53%) participants had ≥2 serum samples and were included in current analyses.
    Of these, 101/186 (54%: 45/101[45%] female, median age 55 years [IQR = 45-64]) reported PASC at 12 and 24 weeks after COVID-19 onset.
    We included 37 reference samples (17/37[46%] female, median age 49 years [IQR = 40-56]).
    In a multivariate model, PASC was associated with raised CRP and abnormal diffusion capacity with raised IL10, IL17, IL6, IP10 and TNFα at 24 weeks.
    Early (0-4 week) IL-1β and BMI at COVID-19 onset were predictive of PASC at 24 weeks.

    Conclusions: Our findings indicate that immune dysregulation plays an important role in PASC pathogenesis, especially among individuals with reduced pulmonary function. Early IL-1β shows promise as a predictor of PASC.

    https://pubmed.ncbi.nlm.nih.gov/39008486/
     

    Attached Files:

  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    27,979
    Location:
    Aotearoa New Zealand
    I haven't read the paper, but this paper does not look to have targeted ME/CFS-type Long Covid.

    54% of the sample reported PASC at 12 and 24 weeks after the acute infection, a majority of males, mostly older, especially among individuals with reduced pulmonary function.

    We haven't seen CRP or most of the usual cytokines reliably associated with ME/CFS-type Long Covid.
     

Share This Page